Consensus McKesson Corporation

Stocks

MCK

US58155Q1031

Pharmaceuticals

Market Closed - NYSE 06:00:02 10/09/26 am AEST			5-day change	1st Jan Change
891.68 ^USD	+0.29%		-3.58%	+8.70%

08/09	McKesson Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 08:00 AM
03/09	Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating	MT

Evolution of the Average Target: McKesson Corporation

Evolution of the Target Price: McKesson Corporation

Changes in Analyst Recommendations: McKesson Corporation

c2.Qb4_Qyb8RmQY9GzrtWCA2tBNDcWLIdsKgWKxDUCxGYY.BYpzD0uodCUhwDvG_gPolpgSZrHDTJ5c6Q76fTf2ceIH2wpxHqs1A1nEVA~a892269ed974656bb624334a70b448cc

Analysts' recommendations: McKesson Corporation

03/09	Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating	MT
20/08	McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says	MT
19/08	RBC Initiates McKesson at Sector Perform With $845 Price Target	MT
18/08	Barclays Raises Price Target on McKesson to $1,000 From $925, Maintains Overweight Rating	MT
11/08	Wells Fargo Adjusts Price Target on McKesson to $933 From $812, Maintains Equalweight Rating	MT
07/08	Mizuho Adjusts Price Target on McKesson to $905 From $885	MT
07/08	TD Cowen Adjusts Price Target on McKesson to $1,006 From $989	MT
07/08	Evercore ISI Adjusts Price Target on McKesson to $1,000 From $860	MT
07/08	Baird Adjusts Price Target on McKesson to $1,015 From $955	MT
07/08	UBS Adjusts Price Target on McKesson to $1,080 From $1,050, Maintains Buy Rating	MT
06/08	BofA Securities Adjusts Price Target on McKesson to $1,050 From $950	MT
23/07	Citigroup Raises McKesson Price Target to $1,000 From $945, Maintains Buy Rating	MT
22/07	Baird Adjusts Price Target on McKesson to $955 From $941, Maintains Outperform Rating	MT
21/07	TD Cowen Adjusts McKesson Price Target to $989 From $1,012, Maintains Buy Rating	MT
21/07	BofA Securities Adjusts McKesson Price Target to $925 From $900	MT
14/07	Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating	MT
07/07	Evercore ISI Adjusts Price Target on McKesson to $860 From $850	MT
10/06	Barclays Cuts McKesson Price Target to $925 From $1,050, Maintains Overweight Rating	MT
05/06	Argus Adjusts Price Target on McKesson to $850 From $1,050, Maintains Buy Rating	MT
14/05	Citigroup Adjusts Price Target on McKesson to $945 From $975, Maintains Buy Rating	MT
12/05	Wells Fargo Adjusts Price Target on McKesson to $812 From $925, Maintains Equalweight Rating	MT
09/05	McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says	MT
08/05	UBS Adjusts McKesson Price Target to $1,050 From $1,000, Maintains Buy Rating	MT
08/05	Deutsche Bank Adjusts McKesson Price Target to $875 From $973, Maintains Buy Rating	MT
28/04	William Blair Initiates McKesson at Outperform	MT

More recommendations

Pharmaceuticals Wholesale

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
MCKESSON CORPORATION		+9.99%
CARDINAL HEALTH, INC.		+12.89%
SIGMA HEALTHCARE LIMITED		+19.78%
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD		+25.97%
HUADONG MEDICINE CO., LTD		+54.16%
H. LUNDBECK A/S		+11.76%
SINOPHARM GROUP CO. LTD.		+35.01%
GALENICA AG	-	+5.23%
SELÇUK ECZA DEPOSU TICARET VE SANAYI		-59.62%
MEDIPAL HOLDINGS CORPORATION		+2.48%
Average		+11.77%
Weighted average by Cap.		+12.61%